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SUMMARY
Background: Children with spina bifida represent
the major risk group for latex sensitization.
Purpose: To determine the prevalence of latex
sensitization in these children and to identify risk
factors.
Material and methods: We studied 57 patients
with spina bifida. The mean age was 5.6 years and
the male/female ratio was 0.8/1. In all patients a
questionnaire, skin prick test (SPT) with latex (UCB-
Stallergènes, Lofarma and ALK-Abelló), common
aeroallergens and fruits (UCB-Stallergènes) and
serum determination of total IgE (AlaSTAT) were
performed.
Results: The prevalence of latex sensitization was
30 %; only two sensitized children (12 %) had
symptoms after exposure. Risk factors for latex
sensitization were age  5 years (p = 0.008; OR = 6.0;
95% CI = 1.7-22.1), having at least four previous surgi-
cal interventions (p < 0.0001; OR = 18.5; 95 %
CI = 3.6-94.8), having undergone surgery in the first
3 months of life (p = 0.008; OR = 5.4; 95 %
CI = 0.7-29.2) and total serum IgE  44 IU/ml
(p = 0.03; OR = 3.8; 95 %CI = 1.1-13.1). Multiple
logistic regression analysis showed that only a history
of four or more surgical interventions (p < 0.0001;
OR = 26.3; 95 %CI = 2.9-234.2) and total serum
IgE  44 IU/ml (p = 0.02; OR = 8.6; 95% CI = 1.4-53.4)
were independently associated with latex
sensitization. Sex, family and personal allergic history,
hydrocephalus with ventriculoperitoneal shunt,
cystourethrograms, intermittent bladder
catheterization and atopy were not related to latex
sensitization.
Conclusions: In children with spina bifida,
significant and independent risk factors identified for
latex sensitization were multiple interventions and
higher levels of total serum IgE. A prospective study
will clarify the clinical evolution of assymptomatic
children sensitized to latex.
Key words: Latex. Spina bifida. Sensitization.
Children. Risk factors.
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INTRODUCTION
The first case of latex allergy was described in
1979 by Nutter (1). Since then, particularly in the last
years, this clinical entity has been more frequently
referred as a cause of urticaria and angioedema,
rhinoconjuntivitis, asthma and anaphylaxis. Most
reactions are mild, but more serious and potentially
lethal situations can occur, with systemic
involvement, namely during surgical and diagnostic
procedures with mucosal exposure to latex products
(2-4). In spite of the diversity of symptoms, in some
studies most sensitized individuals are
assymptomatic (5-8).
The prevalence of latex sensitization in the general
population is unknown, but it seems to be lower than
1 % (8-12). Higher prevalences, determined by some
authors (13, 14), seems to be related with the
diagnostic method used (SPT and/or serum specific
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IgE determination) and the existence of occupational
exposure in the studied populations.
In selected groups, higher prevalences are found.
Hospital workers, through frequent contact with
latex products, have rates of sensitization ranged
between 2.9 % and 16.9 % (9, 15-20). Rubber
industry workers also have high sensitization
prevalence (21). Atopy also seems to be another risk
factor of latex sensitization, mainly if associated with
frequent contact to latex products (22-27).
Children with spina bifida are considered the major
risk group. Several published studies found
prevalences between 4.3 % and 73.3 % (table I) (5-7,
28-42). The variability of results can be related with
differences in the methodology, namely variables
related with the population in study (dimension and
age group) or the diagnostic method (SPT and/or
serum IgE determination, absence of allergenic
extract standardization and different methodology of
SPT).
Several authors tried to identify risk factors for
latex sensitization in children with spina bifida. The
high prevalence of sensitization seems to be a
result, mainly, of early (33, 34, 39-41) and frequent
contact with latex products (7, 29, 30, 33, 37, 39-43).
The exposure begins, frequently, in the first day of
life, with myelomeningocele surgical closure, and
continues during several surgical procedures to
correct neurologic, urologic and orthopedic
congenital malformations. Mucosal contact
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occurring during surgical and diagnostic procedures
(catheterizations and cystourethrograms) promotes
sensitization (28, 41).
The predisposition to produce high levels of
specific IgE in response to allergenic exposure,
related to a high atopic risk, has been a factor
frequently associated to latex sensitization in this
population (7, 29, 30, 37, 40, 41).
The aim of this study was to determine the
prevalence of latex sensitization and to evaluate the
relevance of clinical data (age, gender, personal and/or
family history of atopy and ventriculoperitoneal shunt),
exposure to latex products (precociousness and
number of surgeries, performance of
cystourethrograms and bladder catheterization),
allergenic sensitization and serum levels of total IgE, as




From August to November of 1997, we studied
57 children with spina bifida of the Spina Bifida
Nucleus of Dona Estefânia Hospital, with a mean age
(± SD) of 5.6 (± 4.1) years (aged between 6 months
and 18 years); most of them less than 5 years old
Table I
Prevalence of latex sensitization in children with spina bifida
Author Year N Mean age (years) Diagnostic method Prevalence (%)
Slater et al (28) 1991 32 8.8 Specific IgE 34.4
Yassin et al (29) 1992 76 9.3 SPT 64.5
Moneret-Vautrin et al (30) 1993 86 N.A. SPT 50.6
Kelly et al (31) 1993 86 N.A. SPT 50.6
Kelly et al (32) 1994 60 7.8 Specific IgE 73.3
Pittman et al (33) 1995 87 10.0 SPT 47.0
Konz et al (34) 1995 36 6.3 Specific IgE 63.9
Capriles-Hulett et al (35) 1995 93 6.6 SPT 4.3
Michael et al (5) 1996 81 9.0 SPT 45.7
Ziylan et al (36) 1996 23 6.4 SPT 26.1
Nieto et al (37) 1996 100 7.5 SPT 29.0
Porri et al (38) 1997 29 9.8 SPT/Specific IgE 58.6
Mazón et al (39) 1997 110 10.5 SPT/Specific IgE 29.1
Cremer et al (6) 1998 148 10.8 Specific IgE 40.5
Shah et al (40) 1998 116 N.A. (1 a 20) SPT/Specific IgE 44.0
Niggemann et al (41) 1998 159 10.0 SPT/Specific IgE 55.3
Bernardini et al (7) 1998 59 14.3 SPT/Specific IgE 25.4
Buck et al (42) 2000 161 10.0 SPT/Specific IgE 54.7
N.A. = information not available in the study
(53%). A predominance of female gender was found
(54%), corresponding to a ratio male/female of 0.8/1.
All the children underwent a questionnaire, SPT
and serum total IgE determination. Parents or tutors
consent was obtained for children’s participation. The
study was approved by the Dona Estefânia Hospital
Ethics Committee.
Questionnaire
A trained doctor performed a questionnaire for
allergic diseases in children, evaluating the following
parameters:
– Demographic data.
– Personal and family history of allergic diseases.
– History of latex exposure (number and type of
surgical interventions, bladder catheterization and
cystourethrograms).
– Symptoms upon contact with latex products.
SPT
SPT were performed under medical supervision,
always using the same methodology and respecting
avoidance periods recommended for relevant drugs.
SPT were performed on the anterior face of the
forearm, respecting a minimum distance of 2 cm
between each allergenic extract and using metallic
lancets of perpendicular application on the skin, with
1 mm penetration (Dome Hollister Stier Prick
Lancetter) (44). The following allergenic extracts were
used:
– Latex (three extracts): UCB-Stallergènes,
Lofarma and ALK-Abelló.
– Common aeroallergens (UCB-Stallergènes):
Dermatophagoides pteronyssimus (Dpt), Dermato-
phagoides farinae (Df), mixture of grass and tree
pollen, ragweed, cat and dog.
– Fruits and vegetables (UCB-Stallergènes):
banana, avocado, pineapple, kiwi, apricot, peach,
grape, chestnut and potato.
As a positive reference, we used histamine
extract at 10 mg/ml concentration (45) and as a
negative reference, a phenol solution at 0.5 %, with
no positivity with this reference. SPT response were
interpreted 15 minutes after application, evaluating
wheal area (45) and considering 7 mm2 as positive
cut off. The reading method used consisted of a
digitalized graphics table, connected to a
microcomputer with computer assisted design
(CAD) software, a method previously validated by
our group (46).
Allergol et Immunopathol 2002; 30(1): 5-13
7
G. Pires, M. Morais-Almeida, A. Gaspar, N. Godinho, E. Calado, J. Abreu-Nogueira, J. Rosado-Pinto.— RISK FACTORS FOR LATEX
SENSITIZATION IN CHILDREN WITH SPINA BIFIDA
Latex sensitization was considered when there
was at least one positive SPT, for any of the three
allergenic latex extracts. Atopy was defined as the
existence of at least one positive SPT for common
aeroallergens, excluding latex.
Total IgE
Serum total IgE determination was performed by a
method of radioimmunoassay in
micro-plates-AlaSTAT (Amerlab/Diagnostic Products
Corporation). The results were expressed in IU/ml.
Statistical analysis
Fisher’s exact test was used to evaluate the
differences regarding the studied characteristics
among latex sensitized and non-sensitized children;
p < 0.05 was considered significant. Student’s t test
was used to compare values of total IgE among
latex sensitized and non-sensitized children;
p < 0.05 was considered significant. The relative
importance of the studied characteristics as risk
factors for latex sensitization was obtained through
the determination of the odds ratio, with a
confidence interval of 95 %. A model of multiple
logistic regression was performed, including the
characteristics considered significant in the
univariate analysis method, to identify independent
risk factors for latex sensitization. Statistical analysis
was done with SPSS version 6.0
RESULTS
Latex sensitization
Seventeen of the 57 children studied were
sensitized to latex, corresponding to a sensitization
prevalence of 30 %. The prevalence of sensitization
was 26 % with ALK-Abelló extract, 25 % with
UCB-Stallergènes extract and 25 % with Lofarma
extract. The prevalence of latex sensitization with all
latex extracts was 23 %.
There was no adverse reactions to latex SPT.
Only two of the latex sensitized children (12 %)
had symptoms of latex allergy. A female child 4 years
old, with rhinitis after inflating balloons and history
of 6 surgical interventions. A male child 5 years old,
with urticaria and angioedema after inflating balloons
and contacting with gloves, with a history of
10 surgical interventions.
Demographic data
The mean age of the latex sensitized children was
higher than that of non-sensitized children,
respectively 7.6 (± 4.5) years and 4.8 (± 3.6) years
(p = 0.03). In children with 5 or more years, the
prevalence of latex sensitization was significantly
higher than in the younger group, 48 % to 13 %,
(p = 0.008, OR = 6.0, 95 %CI = 1.7-22.1).
Personal and family history 
of allergic diseases
Family history of allergic diseases (bronchial
asthma, rhinitis, allergic conjunctivitis or atopic
eczema), was present in 49 % of the population.
Personal history of allergic pathology was verified in
23 % of the children (18 % with rhinitis, 11 % with
asthma and 2 % with atopic eczema).
Family history (p = 0.78; OR = 1.2; 95%CI = 0.4-3.9)
or personal history of allergic diseases (p = 0.98;
OR = 1.1; 95%CI = 0.3-4.0) was not identified as risk
factors for latex sensitization.
Hydrocephalus with 
ventriculoperitoneal shunt
Most children (68 %) had hydrocephalus with
ventriculoperitoneal shunt. These children presented
higher prevalence of latex sensitization, 36 % vs
17 % in children with no ventriculoperitoneal shunt,
without statistical significance (p = 0.21; OR = 2.8;
95 %CI = 0.7-11.4).
Surgical interventions
The average number (± SD) of surgical
interventions was 3.7 (± 2.5), ranged 1 to
12 surgeries. The prevalence of latex sensitization
increased with the number of surgical interventions
(fig. 1). The average number of surgeries was
significantly higher (p = 0.0001) in sensitized children,
6.3 (± 2.7) vs 2.7 (± 1.5) in non-sensitized children.
The existence of at least 4 surgeries was
identified as a risk factor for latex sensitization:
p < 0.0001; OR = 18.5; 95 %CI = 3.6-94.8. The
prevalence of sensitization was 56 % in children
submitted to 4 or more surgical interventions,
compared to 6 % in children with less than
4 surgeries
Almost all of the children were precociously
submitted to surgical interventions, 55% in the first
day of their lives, 80 % in the first week and 97 %
before 3 months old. The average number of
surgeries in the first 3 months was 1.9 (± 1.3),
ranged 1 to 8. Latex sensitized children had a higher
average number of interventions in the first 3 months
of life, 2.6 (± 1.9) vs 1.6 (± 0.9) in non-sensitized
children (p = 0.008; OR = 5.4; 95 %CI = 0.7-29.2).
Cystourethrograms and intermittent 
bladder catheterization
Intermittent bladder catheterization, occurring in
the majority of children in study (56 %), was not
identified as a risk factor for latex sensitization
(p = 0.55; OR = 0.8; 95 %CI = 0.2-1.9).
Cystourethrograms, performed in almost half of the
population (49 %), were also not identified as a risk
factor for sensitization (p = 0.89; OR = 1.0;
95%CI = 0.3-3.2).
Prevalence of atopy
The prevalence of atopy was 21 % (12 children).
Eleven of the atopic children (19 %) were sensitized
to house dust mites (Dpt and/or Df). Three children
(5 %) were sensitized to grass and ragweed pollen.
Four children (7 %) were sensitized to fruits and
vegetables (banana, pineapple, apricot and potato),
without symptoms.
There were more latex sensitized children among
the atopic group (50%), in comparison with non-atopic
children (24 %), however without statistical
significance (p = 0.15; OR = 3.1; 95%CI = 0.8-11.6).
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The average value (± SD) of total IgE was 98.9
(± 196.0) IU/ml, corresponding to a geometric average
of 32.0 IU/ml and a median value of 44 IU/ml. The
geometric average for total IgE was significantly higher
in the latex sensitized children, 71.2 vs 22.6 IU/ml in
non-sensitized (p = 0.004). High serum levels of total
IgE was identified as a risk factor for latex sensitization,
46 % of children with total IgE ≥ 44 IU/ml were
sensitized, vs 14% of children with total IgE < 44 IU/ml
(p = 0.03; OR = 3.8; 95%CI = 1.1-13.1).
Multiple logistic regression analysis
We performed a multivariate logistic analysis of
significant risk factors (table II), namely age  5 years,
4 or more surgeries, higher average number of
surgeries in the first 3 months of life and serum total
IgE ≥ 44 IU/ml. It was identified as independent risk
factors for latex sensitization (table III): existence of at
least 4 interventions (p < 0.0001; OR = 26.3; 95 %
CI = 2.9-234.2) and total IgE ≥ 44 IU/ml (p = 0.02;
OR = 8.6; 95%CI = 1.4-53.4).
DISCUSSION
In a population of 57 children with spina bifida the
prevalence of latex sensitization was 30 %, a value
lower than those found in other published studies
(5, 6, 29-34, 38, 40, 41). The age of these children
(most of them younger than 5 years old) can justify
the prevalence of sensitization in our study, as well
as the small number of symptomatic children (12%).
In the studies involving children older than 7.5 years
(5, 6, 28, 29, 32, 33, 38, 41), the prevalence of latex
allergy was higher, varied between 24 % and 63 %.
In the available studies, none of the works included
children with an average age under that observed in
our study. The low prevalence of sensitization found
by Capriles-Hulett et al (35), is probably related to
socioeconomic factors, namely the re-utilisation of
gloves (washing and sterilisation).
The use of different methodology in the diagnosis
of latex sensitization, including serum specific IgE
determination or SPT, in most studies with
non-standardized extracts, prepared from natural
latex or surgical gloves, could justify the disparity of
results.
In our study, the prevalence of sensitization was
determined by SPT, the most sensitive diagnostic
method (30, 31, 40, 47, 48), using three commercial
latex extracts. SPT were performed with no adverse
reaction, contrary to Kelly et al (31), who found a
prevalence of 8 % of systemic reactions.
Several studies tried to identify risk factors for
latex sensitization in children with spina bifida.
Demographic data, such as age (37, 40) and gender
(6), contact with latex products, including number of
surgical interventions (7, 29, 30, 33, 37, 39-43)
performing cystourethrograms and bladder
catheterization (37), existence of hydrocephalus
with ventriculoperitoneal shunt (37, 41, 49), atopy
(7, 29, 30, 37, 40, 41), fruit sensitization (7) and high
levels of total IgE (7, 37) have been identified as risk
factors. Some of these characteristics are related to
each other. Exposure to latex, during surgical
interventions and other diagnostic and therapeutic
procedures, increases with age. Serum levels of
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Table II
Risk factors for latex sensitization in children with spina
bifida – Dona Estefânia Hospital
Variables studied Latex Odds ratio psensitization (95 %CI)
Demographic data
Female 36 % 1.4 (0.5-3.4) 0.39
Age  5 years 48 % 6.0 (1.7-22.1) 0.008
Antecedents of atopy
Family history 32 % 1.2 (0.4-3.9) 0.78
Personal history 31 % 1.1 (0.3-4.0) 0.98
Ventriculoperitoneal 
shunt 36 % 2.8 (0.7-11.4) 0.21
Latex exposure
 4 surgeries 56 % 18.5 (3.6-94.8) < 0.0001
Surgeries in the first
3 months 
(average number) 2.6 (± 1.9) 5.4 (0.7-29.2) 0.008
Cystourethrograms 29 % 1.0 (0.3-3.2) 0.89
Intermittent bladder 
catheterization 25 % 0.8 (0.2-1.9) 0.55
Atopy 50 % 3.1 (0.8-11.6) 0.15
Total IgE  44 IU/ml 46 % 3.8 (1.1-13.1) 0.03
Table III
Risk factors for latex sensitization in children with spina
bifida – Logistic analysis
Risk factor Latex Odds ratio psensitization (95 %CI)
Age  5 years 48 % 1.5 (0.2-9.0) 0.68
 4 surgeries 56 % 26.3 (2.9- 234.2) 0.003
Surgeries in the first 3 months
(average number) 2.6 (± 1.9) 2.3 (0.3-16.0) 0.39
Total IgE  44 IU/ml 46 % 8.6 (1.4-53.4) 0.02
total IgE depend on age and atopy. There are few
studies performing logistic regression analysis,
allowing the identification of significant and
independent risk factors (7, 37, 40).
The importance of a high number of surgeries in
latex sensitization was documented in most studies
(7, 29, 30, 33, 37, 39-43), although the value from
which there is a risk is not usually mentioned.
Bernardini et al (7), in a population of 59 patients with
spina bifida, identified 5 or more surgical
interventions as a risk factor. Niggemann et al (41),
in 159 patients, identified 8 or more surgeries as a
risk factor for sensitization and 9 or more
interventions as a risk for symptoms related to latex
exposure. In only one study (35) the number of
surgeries was not identified as a risk factor,
presenting however a low prevalence of latex
sensitization.
In our study, we verified that the prevalence of
latex sensitization increased with the number of
surgeries, we identified 4 or more interventions as a
risk factor for sensitization, with an adjusted relative
risk of 26.3 (95 %CI from 2.9 to 234.2).
Almost all children studied had been precociously
submitted to surgical interventions, as other authors
had referred (7, 41, 50). There are few studies
identifying early exposure as a risk factor for latex
sensitization, although this has been suggested by
several authors (33, 34, 39-41). Niggemann et al (41),
identified the existence of 3 or more surgeries in the
first year of life as a risk factor for sensitization. 
In our study, the precociousness of interventions,
namely in the first three months of life, proved to be
dependant on the number of surgeries, after
performing multiple logistic regression analysis,
although it had been identified as a risk factor for
sensitization (univariate analysis).
Other forms of latex exposure, including
cystourethrograms and intermittent bladder
catheterization, were not identified as risk factors as
expected, because these procedures in our Hospital
are performed with latex free material. On the
opposite, Nieto et al (37), studying 100 patients with
spina bifida identified both, cystourethrograms and
intermittent bladder catheterization, as risk factors
for sensitization, although with no mention to the
type of material used.
Some authors have documented the existence of
hydrocephalus with ventriculoperitoneal shunt as an
important factor related to latex sensitization in spina
bifida children (37, 41, 49). Early intratectal exposure
and the higher number of surgeries related to shunt,
are possible mechanisms. The hypothesis that
meningeal contact with latex gloves justifies this
higher sensitization was supported by a publication
of a clinical case of a child with ventriculoperitoneal
shunt where latex specific IgE appears to be locally
synthetized in cerebrospinal fluid (51). On the
opposite, in our study, ventriculoperitoneal shunt
was not identified as a risk factor, in spite of a higher
prevalence of sensitization in these patients.
Besides latex exposure during surgical
interventions, atopy is considered by the majority of
authors as the most important risk factor for latex
sensitization in patients with spina bifida (7, 29, 30,
37, 40, 41), as well as for latex allergy (5, 32, 37, 41,
52). Moneret-Vautrin et al (30), suggest the possibility
of a synergetic effect resulting from the combination
of these two factors towards promoting
sensitization.
In our study, the existence of atopy was not a risk
factor for latex sensitization. In this population,
although the atopic children present a sensitization
prevalence of 50 %, vs 24 % in non-atopics, this
difference had no statistical significance. Also
Cremer et al (6), in a study with 148 patients, with a
similar prevalence of atopy (18.4 %), concluded that
this was not a risk factor for latex sensitization.
Capriles-Hulett et al (35), also did not find a
relationship between latex sensitization and atopy.
Some authors suggest that atopy is not a risk
factor for latex sensitization, but inversely the
existence of latex sensitization is a predisposing
factor for the development of atopy (40, 53). Children
who are sensitized to latex and continue to be
exposed to this potent allergen, would present
continuous production of Th2 cytokines pattern, such
as IL-4 and IL-13, favouring sensitization to common
aeroallergens. In our study, the high number of
younger children, mostly under 5, rises the
hypothesis that sensitization to other aeroallergens
has not yet developed. Prospective study could clarify
this supposition.
Some authors suggest that children with spina
bifida are predisposed to be sensitized to latex,
independently of atopic status and level of latex
exposure. The significantly higher prevalence of latex
sensitization in children with spina bifida compared
with patients with other pathologies, with similar
number of surgeries (33, 34, 36, 54) and simi-
lar prevalence of atopy, (33) supports the existence
of a genetic predisposition. This hypothesis was not
confirmed in a study performed by Porri et al (38), in
which the prevalence of latex sensitization was
equivalent in patients with and without spina bifida,
submitted to a similar number of surgeries.
There are few studies regarding the importance of
serum total IgE as a risk factor for latex sensitization
(7, 37). Nieto et al (37), and Bernardini et al, (7)
studying samples of 100 and 59 patients with spina
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bifida, verified that high levels of total IgE, adjusted
to age, was correlated to latex sensitization. Swert et
al (52), studying patients with and without latex
allergy, diagnosed by challenge test (surgical glove
band in the arm) matched by age, gender and
number of surgeries, found that the geometric
average of total IgE was significantly higher in allergic
patients. Kelly et al (32), in a population of 60 children
with spina bifida, identified total IgE > 84 IU/ml as a
risk factor for anaphylactic reaction during surgical
intervention.
In our study, the existence of serum total
IgE  44 IU/ml was identified as an independent risk
factor for latex sensitization, with an adjusted relative
risk of 8.6 (95 %CI from 1.4 to 53.4).
Allergy to latex represents an important health
problem for children with spina bifida, enhancing the
need to implement more aggressive diagnostic and
preventive measures. Direct contact with latex
products in hospital environment, particularly during
surgery, must be avoided in all latex sensitized
children, and ideally in all spina bifida children since
birth. We must stress the need of a detailed
description of the components of all medical
products, which frequently contain small amounts of
hidden allergens.
Cremer et al (55), in a pioneer study, recently,
demonstrated that primary prevention could avoid the
appearance of latex sensitization in children with
spina bifida. The authors performed a prospective
study with 2 years of duration, involving 12 new-
borns with spina bifida, which underwent surgery in a
latex-free environment since the first day of their
lives, verifying that none of these children were
sensitized. In comparison, in a sample of 8 children
with spina bifida, submitted to equivalent number of
surgeries with no avoidance measures, 38 % were
sensitized to latex before they were 2 years old.
However, these results need confirmation by studies
with longer duration and involving more patients.
The natural history of assymptomatic sensitized
children, as well as children not yet sensitized, with
sustained latex exposure, remains to be clarified.
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RESUMEN
Introducción: Los niños con espina bífida son el
principal grupo de riesgo para sensibilización al latex.
Objetivo: Se pretendió con este estudio
determinar la prevalencia e identificar factores de
riesgo para sensibilización al latex en niños con
espina bífida.
Método: Se estudiaron 57 niños con espina bífida,
con una edad media de 5,6 años y una relación sexo
masculino/femenino de 0,8/1. A todos los niños le
realizamos cuestionario, pruebas cutáneas en prick
incluyendo latex (extractos UCB-Stallergènes, Lofarma
y ALK-Abelló), aeroalergenos comunes y frutos
(UCB-Stallergènes) y determinación sérica de IgE total
(AlaSTAT).
Resultados: La prevalencia de sensibilización al
latex fue del 30 %; sólo dos niños sensibilizados
(12%) presentaban sintomatología relacionada con la
exposición. Fueron identificados como factores de
riesgo para sensibilización al latex: edad  5 años
(p = 0,008; OR = 6,0; IC95% = 1,7-22,1); existencia de
4 o más intervenciones quirúrgicas (p < 0,0001;
OR = 18,5; IC95 % = 3,6-94,8); cirugías en los
primeros tres meses de vida (p = 0,008; OR = 5,4;
IC95 % = 0,7-29,2); niveles séricos de IgE
total  44 UI/ml (p = 0,03; OR = 3,8;
IC95 % = 1,1-13,1). Mediante la realización de un
análisis de regresión logística múltiple se identificaron
como factores de riesgo independientes, historia de
4 o más intervenciones quirúrgicas (p < 0,0001;
OR = 26,3; IC95 % = 2,9-234,2) y niveles séricos de
IgE total  44 UI/ml (p = 0,02; OR = 8,6;
IC95 % = 1,4-53,). No se identificaron como factores
de riesgo, el sexo, antecedentes familiares y
personales de enfermedad alérgica, hidrocefalia con
derivación ventrículoperitoneal, cistografias,
cateterismo vesical intermitente ni atopia.
Conclusiones: Identificamos como factores de
riesgo significativo e independientes para
sensibilización al latex en niños con espina bífida la
existencia de un número elevado de intervenciones
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quirúrgicas y niveles séricos más elevados de IgE
total. Un estudio prospectivo esclarecerá la evolución
clínica de los niños sensibilizados asintomáticos.
Palabras clave: Latex. Espina bífida. Sensibilización.
Niño. Factor de riesgo.
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